A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Participants (MK-8189-010)
Clinical trial NCT06626464 · COMPLETED
Trial details
- NCT number
- NCT06626464
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-13
- Primary completion
- 2022-07-08
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.